James' timing may be off but I still believe there is a deal in the works, just a matter of time. Having an agreement in place before the MAA submission would help speed things along, I believe. Based on this statement, it appears to have been partially filed, “EMA’s issuance of this certification is a major milestone for Advaxis,” said Daniel J. O’Connor, President and CEO. “With a significant portion of the MAA now reviewed and certified, we are preparing to file the complete MAA as we work to bring this innovative immunotherapy to patients with metastatic cervical cancer who have limited treatment options.”
BTW, PM received, thanks.
Market Data 
Markets 
